Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ligands and Beyond: Mechanosensitive Adhesion GPCRs. | Pharmaceuticals (Basel) | 2022 | 35215331 | PubTator, text mining | PubMed |
| Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis. | J Pers Med | 2022 | 35207772 | PubTator, text mining | PubMed |
| The Ehlers-Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism. | Genes (Basel) | 2022 | 35205310 | PubTator, text mining | PubMed |
| New Insights into the Role of the Complement System in Human Viral Diseases. | Biomolecules | 2022 | 35204727 | PubTator, text mining | PubMed |
| Role of MBL2 Polymorphisms in Sepsis and Survival: A Pilot Study and In Silico Analysis. | Diagnostics (Basel) | 2022 | 35204551 | PubTator, text mining | PubMed |
| Synergy of Human Platelet-Derived Extracellular Vesicles with Secretome Proteins Promotes Regenerative Functions. | Biomedicines | 2022 | 35203448 | PubTator, text mining | PubMed |
| Complement System: An Immunotherapy Target in Colorectal Cancer. | Front Immunol | 2022 | 35173724 | PubTator, text mining | PubMed |
| Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results. | Haematologica | 2022 | 35172561 | PubTator, text mining | PubMed |
| Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis. | JCI Insight | 2022 | 35167491 | PubTator, text mining | PubMed |
| Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19. | Int J Mol Sci | 2022 | 35163504 | PubTator, text mining | PubMed |
| The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment. | Int J Mol Sci | 2022 | 35163273 | PubTator, text mining | PubMed |
| Cerebellar Agenesis and Bilateral Polimicrogyria Associated with Rare Variants of CUB and Sushi Multiple Domains 1 Gene (CSMD1): A Longitudinal Neuropsychological and Neuroradiological Case Study. | Int J Environ Res Public Health | 2022 | 35162247 | PubTator, text mining | PubMed |
| Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. | J Clin Med | 2022 | 35160128 | PubTator, text mining | PubMed |
| Transcriptomic Response to Acidosis Reveals Its Contribution to Bone Metastasis in Breast Cancer Cells. | Cells | 2022 | 35159353 | PubTator, text mining | PubMed |
| Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration. | Cells | 2022 | 35159297 | PubTator, text mining | PubMed |
| Rapid Generation of Ventral Spinal Cord-like Astrocytes from Human iPSCs for Modeling Non-Cell Autonomous Mechanisms of Lower Motor Neuron Disease. | Cells | 2022 | 35159209 | PubTator, text mining | PubMed |
| Systemic lupus erythematosus as a genetic disease. | Clin Immunol | 2022 | 35149194 | PubTator, text mining | PubMed |
| Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease. | Neurobiol Dis | 2022 | 35143967 | PubTator, text mining | PubMed |
| Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health. | Cell Prolif | 2022 | 35141964 | PubTator, text mining | PubMed |
| Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. | Alzheimers Res Ther | 2022 | 35139885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=42